March 24, 2015 - Omaha Fire Department First to Use ZOLL RescueNet ePCR to Submit NEMSIS 3 Data


Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637
[email protected]


One of First EMS Agencies Nationwide to Meet Higher Reporting Requirements

March 24, 2015—CHELMSFORD, MASS.—ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that the Omaha Fire Department is actively using RescueNet® ePCR 6.0 to submit NEMSIS Version 3 data to the State of Nebraska. Omaha Fire Department is the first ZOLL customer and one of the first agencies in the country to submit NEMSIS Version 3 data to its state.

NEMSIS Version 3 incorporates new data elements to reflect the growth of the medical community’s knowledge about treating conditions such as stroke, STEMI, trauma, and out-of-hospital cardiac arrest. NEMSIS Version 3 is also an important step towards harmonizing EMS data with patient data in the hospital. Currently, only two states, Nebraska and California, are actively collecting NEMSIS Version 3 data. All states are expected to transition to NEMSIS Version 3 in the next 6 to 18 months.

“The partnership between ZOLL and Omaha Fire Department will benefit the citizens of Omaha in numerous ways. Omaha Fire Department will collect our data in a way that allows us to work with researchers to identify trends in patients, patient care, and patient outcomes,” said Bill Bernard, Battalion Chief, Omaha Fire Department. “This will lead to improved patient care for the citizens of Omaha and establish Omaha Fire and ZOLL as leaders in national EMS patient care issues.”

“The strategic partnership between ZOLL and Omaha Fire Department allowed for a safe testing environment with both organizations equally committed to success,” said Alex Moghadam, President of ZOLL Data Management Products. “The alliance paves the way for other EMS agencies to make a successful transition to NEMSIS Version 3. Now all of our customers will be able to meet the new, higher standard of state and national reporting requirements and will be ready to adapt to the future of data connectivity between health care providers.”

About the RescueNet ePCR Suite

The RescueNet ePCR Suite is a pre-hospital patient care data collection and reporting application that assists medics in quickly generating complete, real-time electronic patient care reports in the field. Through automation and customization, users can speed up the data collection process and improve the quality of data collected, which can lead to improved patient outcomes.

About ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit

About Asahi Kasei

The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 29,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit

©2015 ZOLL Medical Corporation. All rights reserved. RescueNet and ZOLL are registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All trademarks are the property of their respective owners.